Loading
Latest filing published 04 Jun 2026 for Envoy Medical, Inc., €17k.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brent T. Lucas appears in our data through filings on Envoy Medical, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 21 November 2023 to 29 May 2026, the count stands at 9 filings.
The open-market record is one-sided, with 3 purchases worth €32k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 4 share grants. In 2026 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €8,953. Of 3 purchases, 1 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
Most recently, on 4 June 2026, the filings show a share grant worth €17k in Envoy Medical, Inc. The last insider purchase was made public on 17 February 2026, 250 days ago. The median gap between a trade and its publication by SEC (Form 4) is 5 days. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations